戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n the absence of factor B, and by purinergic P2 receptor antagonists.
2 (2+)]i oscillations, which were abolished by P2 receptor antagonists.
3 reduced or abolished by prior application of P2 receptor antagonists.
4 dently reduced in the presence of ATPases or P2 receptor antagonists.
5 l CO2/H+ sensitivity by an amount similar to P2 receptor antagonists.
6 ng expansion, and were reversibly blocked by P2 receptor antagonists.
7                           In the presence of P2 receptor antagonists A2P5P or AR-C67085, LIBS6 failed
8 nical strain and was completely blocked by a P2 receptor antagonist and by inhibition of p38/mitogen-
9  terms of insensitivity to blockade by known P2 receptor antagonists and the ineffectiveness of adeno
10                      Suramin, a nonselective P2 receptor antagonist, and MRS-2179, a P2Y1 receptor-se
11                      However, treatment with P2 receptor antagonists did not alter the ratio of nesti
12          Suramin (500 mum), a broad-spectrum P2 receptor antagonist, dilated retinal arterioles by 50
13              Pretreatment of astrocytes with P2 receptor antagonists, including suramin and periodate
14 sly we have shown that injection of PPADS, a P2 receptor antagonist, into the arterial supply of skel
15 n, and the acyclic approach to the design of P2 receptor antagonists is valid.
16                                              P2 receptor antagonists or P2Y(6) antisense oligonucleot
17                                   Similarly, P2 receptor antagonists or SC49992 blocked ADP-induced a
18          Attenuation of this response by the P2 receptor antagonist PPADS suggests that bradykinin-in
19 L67156 and were depressed in the presence of P2 receptor antagonists PPADS (10 microm) and suramin (5
20                       Novel analogues of the P2 receptor antagonist pyridoxal-5'-phosphate 6-azopheny
21  ATP receptors in the VLM (microinjection of P2 receptor antagonist pyridoxal-5'-phosphate-6-azopheny
22 and hP2X(2b) receptors were sensitive to the P2 receptor antagonist pyridoxal-5-phosphate-6-azophenyl
23 agal neurons which were blocked by the broad P2 receptor antagonist pyridoxal-phosphate-6-azophenyl-2
24 agal neurons which were blocked by the broad P2 receptor antagonist pyridoxal-phosphate-6-azophenyl-2
25                             Analogues of the P2 receptor antagonists pyridoxal-5'-phosphate and the 6
26 gent of ADP degradation), suramin (a general P2 receptor antagonist), pyridoxal 5'-phosphonucleotide
27 ve antagonist, MRS2179, and the nonselective P2 receptor antagonists, pyridoxal phosphate 6-azophenyl
28 lphabetam-ATP were blocked completely by the P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2'
29             In the isolated retina, suramin (P2 receptor antagonist) reduces the frequency of spontan
30 sion of GFAP and MMP-9 and a purinergic ATP (P2) receptor antagonist reduction in calcium response id
31                                              P2 receptor antagonist studies indicated a role for P2X2
32                    These were blocked by the P2 receptor antagonist suramin (100 microm).
33                                          The P2 receptor antagonist suramin inhibited these intercell
34 lement pathway Ab eculizumab, the purinergic P2 receptor antagonist suramin, and EDTA.
35 ntagonist oxidized ATP (oATP) but not by the P2 receptor antagonist suramin; both ATP and BzATP incre
36 s blocked by ionophoretic application of the P2 receptor antagonists suramin (0.02 M) and pyridoxal-p
37 0.1-30 micrometer) and were sensitive to the P2 receptor antagonists suramin and iso-PPADS.
38                                          The P2 receptor antagonists suramin and pyridoxalphosphate-6
39                       In the presence of the P2-receptor antagonist suramin (0.1 mM), the amplitude o
40 ist sulfonylphenyl theophylline, but not the P2-receptor antagonist suramin, antagonized the effect o
41 ed by apyrase inactivation of nucleotidases, P2 receptor antagonists, tetrodotoxin (TTX), or piroxica
42            These effects were blocked by the P2 receptor antagonists XAMR 0721, periodate-oxidized AT

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。